Document is current

Article History

Received: 25 September 2017

Accepted: 1 October 2018

First Online: 19 October 2018

Ethics approval and consent to participate

: The study was approved by the University of Alberta Health Research Ethics Board (Pro00023191; Tailoring Educational Interventions in Acute Asthma). Written informed consent was waived; patients and PCPs’ voluntary responses/participation reflected their consent to take part in the study.

: Not applicable.

: Dr. Rowe has received research funding from the following respiratory companies as a site principal investigator for multi-centred trials (CEMPRA: Chapel Hill, NC, USA), investigator-initiated research (Merck, Inc.: Montreal, Quebec, Canada) or speaking (Pfizer: New Jersey, USA; Merck, Inc.: Montreal, Quebec, Canada). All payments were made to the University of Alberta. Data from this study were presented at the following scientific meeting: Canadian Association of Emergency Physicians Annual Scientific Meeting, Quebec City, Quebec, Canada; June 8, 2016. Abstract citation: Villa-Roel C, Ospina M, Majumdar SR, Couperthwaite S, Rawe E, Nikel T, Rowe BH. Considering perceptions of patients and knowledge users in the design of an emergency-based acute asthma educational trial. CJEM. 2016; 18:S116.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.